Avellino Names Jon Robson as CEO and Member of the Board of Directors

Avellino Names Jon Robson as CEO and Member of the Board of Directors

November 17, 2021

Jon Robson has been appointed as the new CEO and member of the Board of Directors of Avellino Lab USA. Mr. Robson takes over for previous Avellino CEO Jim Mazzo, who has moved to an advisory role with the company.

Mr. Robson will be in charge of the company's next phase of innovation and growth, which will include combining Avellino's genetic expertise with machine learning, artificial intelligence, and big data.

This powerful partnership will enable the company to continue developing life-changing diagnostics and treatments that improve patient outcomes while also curating a diverse genetic database.

“The Board of Directors and I are thrilled to welcome Jon to the Avellino team and are confident he is the right leader to help usher in our next chapter of growth. This chapter leans heavily into leveraging the latest technologies to advance our pipeline of genetic-based diagnostics and therapies, which will be fueled by the development of a diverse and robust genetic database,” Avellino Founder and Chairman Gene Lee said in a company news release.

“Jon has deep experience in identifying market opportunities and leading high-performing organizations, along with strong technical acumen, and I greatly look forward to partnering with him during this exciting time for the entire Avellino team. I also want to take this time to thank Jim Mazzo for his tremendous leadership and I greatly look forward to partnering with him in his new role as senior advisor.”

“Avellino has a truly innovative approach to solving some of the most significant challenges in health,” Mr. Robson said. “By combining extraordinary knowledge of the human genome with the latest in technology, including machine learning and AI, the company is on an exciting path of developing diagnostics and therapies that will transform lives. I am truly excited to join as CEO and to help contribute to improving health globally.”

Mr. Robson has extensive expertise with both early-stage technology companies and major international data enterprises in generating value from data and analytics.

He was the CEO of MoneyLine Telerate, the President of Thomson Reuters Enterprise Division, the CEO of NYSE Technologies, the President of First Derivatives plc, and the President of DXC Luxoft's Capital Markets division.

Former CEO Jim Mazzo states, “It has been an honor and pleasure to serve Avellino. I look forward to continuing to support the company in an advisory role, and I wish Jon every success as he leads Avellino in its next phase of growth.”